Allos Therapeutics, Inc. to Report First Quarter 2011 Results on May 10, 2011

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that the Company will report its financial results for the first quarter ended March 31, 2011 on Tuesday, May 10, 2011, after the financial markets close. Following the release of the financial results, Allos management will provide a corporate update and review of the first quarter 2011 results via conference call and audio webcast. Access to the conference call and webcast may be obtained as follows: